Literature DB >> 24401902

Prevalence and clinical relevance of allergic rhinitis in patients with classic asthma and cough variant asthma.

Tomoko Tajiri1, Akio Niimi, Hisako Matsumoto, Isao Ito, Tsuyoshi Oguma, Kojiro Otsuka, Tomoshi Takeda, Hitoshi Nakaji, Hideki Inoue, Toshiyuki Iwata, Tadao Nagasaki, Michiaki Mishima.   

Abstract

BACKGROUND: A clinically relevant relationship between classic asthma and allergic rhinitis has been reported. However, the possible link between cough variant asthma (CVA) and allergic rhinitis remains unknown.
OBJECTIVES: To clarify the prevalence and clinical relevance of perennial allergic rhinitis or seasonal allergic rhinitis in CVA patients compared to classic asthma patients.
METHODS: We retrospectively studied adult patients with classic asthma (n = 190) and those with CVA (n = 83). The prevalence of perennial allergic rhinitis or seasonal allergic rhinitis and associations of concomitant perennial or seasonal allergic rhinitis with asthma severity, forced expiratory volume in 1 s (% predicted), fractional exhaled nitric oxide (FeNO) levels, and eosinophil proportions in sputum and blood were analyzed in the two groups.
RESULTS: The prevalence of perennial allergic rhinitis and/or seasonal allergic rhinitis was significantly higher in classic asthma patients than in CVA patients (all p < 0.05). Concomitant perennial allergic rhinitis was associated with higher FeNO levels and eosinophil proportions in sputum and blood in classic asthma patients (p = 0.035, p = 0.036, and p = 0.008, respectively) and with higher asthma severity, FeNO levels, and sputum eosinophil proportions in CVA patients (p = 0.031, p = 0.007, and p = 0.010, respectively). Concomitant seasonal allergic rhinitis was only associated with higher sputum eosinophil proportions in CVA patients with active rhinitis symptoms during the sensitized pollen season (p = 0.025).
CONCLUSIONS: Perennial allergic rhinitis may be relevant for CVA patients as well as classic asthma patients by consistently augmenting eosinophilic lower airway inflammation.
© 2013 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24401902     DOI: 10.1159/000355706

Source DB:  PubMed          Journal:  Respiration        ISSN: 0025-7931            Impact factor:   3.580


  8 in total

1.  Retrospective Study of the Effects of Post-nasal Drip Symptoms on Cough Duration.

Authors:  Takeo Nakajima; Tatsuya Nagano; Yoshihiro Nishimura
Journal:  In Vivo       Date:  2021 May-Jun       Impact factor: 2.155

2.  Impact of fractional exhaled nitric oxide on the outcomes of lung resection surgery: a prospective study.

Authors:  Keigo Okamoto; Kazuki Hayashi; Ryosuke Kaku; You Kawaguchi; Yasuhiko Oshio; Jun Hanaoka
Journal:  J Thorac Dis       Date:  2020-05       Impact factor: 2.895

3.  Pattern of Response to Bronchial Challenge with Histamine in Patients with Non-Atopic Cough-Variant and Classic Asthma.

Authors:  Vladimir Zugic; Natasa Mujovic; Sanja Hromis; Jelena Jankovic; Mirjana Drvenica; Aleksandra Perovic; Ivan Kopitovic; Aleksandra Ilic; Dejan Nikolic
Journal:  J Clin Med       Date:  2018-07-12       Impact factor: 4.241

4.  Value of Exhaled Nitric Oxide and FEF25-75 in Identifying Factors Associated With Chronic Cough in Allergic Rhinitis.

Authors:  Xiaofang Liu; Xiangdong Wang; Xiujuan Yao; Yuhong Wang; Yongchang Sun; Luo Zhang
Journal:  Allergy Asthma Immunol Res       Date:  2019-11       Impact factor: 5.764

5.  A multicenter, prospective, observational study on montelukast monotherapy or montelukast-based combinations treating cough variant asthma.

Authors:  Jiangtao Lin; Zaiyi Wang; Chen Qiu; Zhen Wang; Shanping Jiang; Huaping Tang; Xuefen Wang; Zhongmin Qiu; Yong He; Jianping Zhao; Guochao Shi; Shenghua Sun; Limin Wang; Lin Chen; Jue Wang; Annhua Mao
Journal:  J Thorac Dis       Date:  2020-11       Impact factor: 2.895

6.  Clinical and Inflammatory Characteristics of the Chinese APAC Cough Variant Asthma Cohort.

Authors:  Kefang Lai; Wenzhi Zhan; Feng Wu; Yunhui Zhang; Lin Lin; Wen Li; Fang Yi; Ziyu Jiang; Yuanrong Dai; Suyun Li; Jiangtao Lin; Yadong Yuan; Yong Jiang; Chen Qiu; Limin Zhao; Meihua Chen; Zhongmin Qiu; Hu Li; Ruchong Chen; Wei Luo; Jiaxing Xie; Chunxing Guo; Mei Jiang; Xiaohong Yang; Guochao Shi; Dejun Sun; Rongchang Chen; Kian Fan Chung; Huahao Shen; Nanshan Zhong
Journal:  Front Med (Lausanne)       Date:  2022-01-21

7.  Effects of treatment with montelukast alone, budesonide/formoterol alone and a combination of both in cough variant asthma.

Authors:  Fang Yi; Chen Zhan; Baojuan Liu; Hu Li; Jianmeng Zhou; Jiaman Tang; Wen Peng; Wei Luo; Qiaoli Chen; Kefang Lai
Journal:  Respir Res       Date:  2022-10-10

8.  Analysis of Prevalence and Risk Factors of Adult Self-Reported Allergic Rhinitis and Asthma in Plain Lands and Hilly Areas of Shenmu City, China.

Authors:  Huiping Gao; Yongliang Niu; Qiang Wang; Guangliang Shan; Chao Ma; Haiying Wang; Yaoda Hu; Kai Guan; Jianqing Gu; Jing Wang; Tao Wang; Hongmei Zhao; Hui Han; Haiyuan Chen; Wenxia Ruan; Hanlin Zhang; Cong Cong; Lianglu Wang; Yonglin Liu
Journal:  Front Public Health       Date:  2022-01-04
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.